Tg Therapeutics (TGTX) Restructuring Costs (2011 - 2020)
Tg Therapeutics (TGTX) posted quarterly Restructuring Costs of $16.2 million for Q4 2020, up 452.33% year-over-year from $2.9 million in Q1 2020, and up 39.42% quarter-over-quarter from $11.6 million in Q3 2020.
Tg Therapeutics (TGTX) Restructuring Costs (2011 - 2020) Analysis & Trends
Tg Therapeutics' Restructuring Costs history runs 10 years deep, the most recent figure standing at $16.2 million for Q4 2020.
- In Q4 2020, Restructuring Costs rose 452.33% year-over-year to $16.2 million; the TTM figure through Dec 2020 stood at $41.5 million (up 336.85% YoY), while the FY2020 annual figure was $41.5 million, up 336.9% from the prior year.
- Restructuring Costs for Q4 2020 stood at $16.2 million, up from $11.6 million in the prior quarter.
- The five-year high for Restructuring Costs was $16.2 million in Q4 2020, with the low at $1.1 million in Q1 2016.
- The 5-year median for Restructuring Costs is $1.9 million (2018), against an average of $3.5 million.
- The sharpest annual moves came in 2019 and 2020: Restructuring Costs retreated 8.02% in 2019, then surged 452.33% in 2020.
- Tg Therapeutics' Restructuring Costs stood at $1.3 million in 2016, then jumped by 33.55% to $1.8 million in 2017, then declined by 6.0% to $1.7 million in 2018, then jumped by 76.04% to $2.9 million in 2019, then soared by 452.33% to $16.2 million in 2020.
- Business Quant data shows TGTX's Restructuring Costs at $16.2 million in Q4 2020, $11.6 million in Q3 2020, and $8.6 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 16.15 Mn |
| Sep 30, 2020 | 11.58 Mn |
| Jun 30, 2020 | 8.62 Mn |
| Mar 31, 2020 | 5.17 Mn |
| Dec 31, 2019 | 2.92 Mn |
| Sep 30, 2019 | 2.32 Mn |
| Jun 30, 2019 | 2.31 Mn |
| Mar 31, 2019 | 1.95 Mn |
| Dec 31, 2018 | 1.66 Mn |
| Sep 30, 2018 | 1.79 Mn |
| Jun 30, 2018 | 2.31 Mn |
| Mar 31, 2018 | 2.12 Mn |
| Dec 31, 2017 | 1.77 Mn |
| Sep 30, 2017 | 1.40 Mn |
| Jun 30, 2017 | 1.53 Mn |
| Mar 31, 2017 | 1.33 Mn |
| Dec 31, 2016 | 1.32 Mn |
| Sep 30, 2016 | 1.25 Mn |
| Jun 30, 2016 | 1.45 Mn |
| Mar 31, 2016 | 1.10 Mn |